Abgenics is developing engineered antibodies in two formats: Heavy chain antibodies derived from camels (VHH) and short chain variable fragments (scFv) from mice and humans.

Both formats offer unique properties that can be leveraged for different applications. Abgenics has over the years developed expertise in all the useable antibody formats and its reformatting.